76 results
DEFA14A
SLNO
Soleno Therapeutics Inc
30 Apr 18
Additional proxy soliciting materials
6:17am
of transaction:
Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0
DEFA14A
SLNO
Soleno Therapeutics Inc
29 Apr 19
Additional proxy soliciting materials
6:20am
:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
ended September 30, 2021. The decrease of was primarily due to a larger decrease in the fair value of our outstanding warrants, partially offset
8-K
EX-99.1
siq1k
18 Mar 19
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
4:37pm
424B3
gsuxm4u75xvx6i9wt6jf
24 Jul 17
Prospectus supplement
12:00am